Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 November 2019 | Story Leonie Bolleurs | Photo Johan Roux
Prof Zakkie Pretorius
Prof Zakkie Pretorius, Research Fellow at the UFS Department of Plant Sciences.

Prof Zakkie Pretorius, Research Fellow, and Prof Botma Visser, Associate Professor, both from the Department of Plant Sciences at the University of the Free State (UFS), partnered in a ground-breaking research project headed by Dr Melania Figueroa from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia. Together, these scientists solved a 20-year-old mystery, uncovering the origins of one of the world’s deadliest strains of cereal rust disease.

The manuscript, with the title, Emergence of the Ug99 lineage of the wheat stem rust pathogen through somatic hybridisation, was accepted for publication in Nature Communications.

According to a statement released by CSIRO, research shows that the devastating Ug99 strain of the wheat stem-rust fungus was not the result of a sexual cross between different rust strains as previously thought, but in fact was created when fungal strands simply fused to create a new hybrid strain.

This process is called somatic hybridisation and enables fungi to merge their cells and exchange genetic material without going through a complex sexual reproduction cycle. The study found that half of Ug99’s genetic material came from a strain that occurred in Southern Africa around 100 years ago and eventually spread to Australia.

The discovery implies that other crop-destroying rust strains could hybridise elsewhere with Ug99, for example, to exchange genetic material and create a whole new enemy.

While there was some speculation that rust strains could hybridise – based on laboratory studies in the 1960s as well as some earlier studies on the topic – this comprehensive research now provided the first genomic evidence that the process can generate new strains.

History of Ug99

Prof Pretorius was the first person to describe the dangerous Ug99 isolate, confirming the ability of the isolate to leave the Sr31 resistance gene ineffective (up to that time, effective against all known wheat stem-rust races). This laid the basis for international concern.

He named the field sample Ug99, based on the country of origin (Uganda) and year of sample collection (1999). 

“The Sr31 resistance gene and associated traits were so effective that the gene occurred in almost 70% of CIMMYT’s (Mexican-based International Maize and Wheat Improvement Center) spring wheat germplasm. In addition, many popular cultivars containing the gene were released around the world.”

“Ug99 then disappeared for a few years. When the race re-appeared in East Africa, it caused localised but severe epidemics,” he said.

Prof Pretorius continues: “Leading wheat breeders and pathologists were concerned that Ug99 could destroy wheat production in many global regions where wheat is critical for food security. Thus, in 2005, Dr Norman Borlaug, Nobel laureate and father of the green revolution, called for a meeting in Kenya where a global effort to combat the threat was initiated. The international wheat research community was mobilised and with funding primarily from the Bill and Melinda Gates Foundation and coordinated by Cornell University in the USA, research commenced.”

wheat stem rust

Wheat stem rust 14: Rust diseases are the cause of extensive crop losses each year. With this recent discovery, published in 
Nature Communications, scientists can now better identify the resistance genes which can be bred into wheat varieties to give crops 
long-lasting protection against rust. (Photo: Supplied) 

“From field trials in Kenya, it soon became apparent that 90% of the world’s wheat varieties were susceptible to Ug99. Although breeding and selection for resistance started in earnest, the pathogen adapted, gaining virulence for other previously effective resistance genes. At present, 13 races have been described within the Ug99 group occurring in 13 countries, mostly in Africa, but also in Yemen and Iran. Five of these races are present in South Africa, all confirmed by scientists from the UFS and ARC-Small Grain in Bethlehem. The original Ug99 has, however, never been detected in South Africa.”

Combined efforts

Rusts are common fungal diseases of plants. The spores of the fungus attach themselves to the stems and leaves of wheat plants and essentially suck the nutrients from the plant. Plants either die or produce shrivelled and low-quality grain. 

Group Leader at CSIRO, Dr Melania Figueroa, agrees that Ug99 is considered the most threatening of all rusts, as it has managed to overcome most stem rust-resistance genes used in wheat varieties.

“There is some good news, however; the better you know your enemy, the more equipped you are to fight against it. Knowing how these pathogens come about means we can better predict how they are likely to change in the future and better determine which resistance genes can be bred into wheat varieties to give long-lasting protection.”

Earlier this year, CSIRO worked with the University of Minnesota and the 2Blades Foundation to improve wheat resistance by stacking five resistance genes into the one wheat plant to combat wheat stem rust. 

The breakthrough came as Dr Figueroa’s group was sequencing Ug99 (then at the University of Minnesota), and at the same time a CSIRO team led by Dr Peter Dodds was sequencing Pgt21 in Australia (Pgt21 is a rust strain that was first seen in South Africa in the 1920s and believed to have been carried to Australia in the 1950s by wind currents). When the two groups compared results, they found that the two pathogens share an almost identical nucleus and therefore half of their DNA.

“This discovery will make it possible to develop better methods to screen for varieties with strong resistance to disease,” said Dr Figueroa.

Molecular fingerprinting

In addition to infection studies, molecular fingerprinting by members of the South African Ug99 race group led by Prof Botma Visser at the UFS, confirmed their genetic placement in context with Ug99 and other global stem rust races. The availability of the original Ug99 collection, along with other local rust isolates in long-term storage at the UFS, was essential to the success of the current research.

Despite the continued evolution of stem-rust variants, excellent progress has been made worldwide in the breeding of resistant wheat cultivars, including in South Africa. With funding from the Winter Cereal Trust, Dr Willem Boshoff, Senior Lecturer in the Department of Plant Sciences at the UFS, is responsible for the annual testing of all commercial wheat cultivars and advanced breeding lines for appropriate stem rust races.

Dr Melania Figueroa
Dr Melania Figueroa from the Commonwealth Scientific and Industrial Research Organisation (CSIRO). Photo: Kate Langford

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept